To main content To main navigation

Lara Barazzuol

Head of Cancer treatment-induced neurocognitive dysfunction, Principal Investigator Profile

Head of Cancer treatment-induced neurocognitive dysfunction, Principal Investigator

Contact information

Discover our research

Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation

2024, STEM CELLS

Effects of the adenosine A2A receptor antagonist KW6002 on the dopaminergic system, motor performance, and neuroinflammation in a rat model of Parkinson's disease.

2024, Neuropharmacology

All publications

Roles

- ESTRO 2024Lara Barazzuol (Please select a role) 3-May-2024 → 7-May-2024 Organising and contributing to an event > Academic
- Board member of the Dutch Society for Stem Cell Research (DSSCR) (External organisation)Lara Barazzuol (Please select a role) 1-Apr-2024 → Membership > Academic
- Mechanisms of cancer treatment-induced neurocognitive declineLara Barazzuol (Speaker) 15-Dec-2022 Academic presentation > Academic
- Board member of of the Netherlands Society for Radiobiology (Nederlandse Vereniging voor Radiobiologie, NVRB) (External organisation)Lara Barazzuol (Please select a role) 11-Nov-2022 → Membership > Academic
- Mechanisms of cancer treatment-induced neurocognitive declineLara Barazzuol (Speaker) 19-Oct-2022 Academic presentation > Academic
All activities
- Adrian C. Begg AwardLara Barazzuol, 2017 Academic
- Bas Mulder AwardLara Barazzuol, 2017 Academic
- European Radiation Research Society Best Poster AwardLara Barazzuol, 2016 Academic
- British Institute of Radiology Nic McNally AwardLara Barazzuol, 2015 Academic
- International Congress of Radiation Research 2015 Young Investigator AwardLara Barazzuol, 2015 Academic
All prizes

Contact